CTRI

As institutional ethical committee approval obtained, written and informed consent will be taken from the patient. The study will be conducted in 100 patients between 18 to 60 years of age, ASA-I and ASA-II of either gender with fracture of clavicle electively posted for open reduction and internal fixation Patients will be randomly allocated into one of the following groups Group I and Group II using computer generated random number table

Group I: Patients in this group will receive superficial cervical plexus block with 7 ml of 0.375% Ropivacaine and clavipectoral fascial plane block with 20 ml of 0.375% of Ropivacaine under ultrasound guidance

Group II: Patients in this group will receive superficial cervical plexus block with 7 ml of 0.375% Ropivacaine and interscalene brachial plexus block using 20 ml of 0.375% ropivacaine under ultrasound guidance

All the patients in the study will be subjected to a thorough pre-anaesthetic evaluation which includes a detailed history taking, complete general physical examination and necessary relevant investigations like complete blood count, blood urea, serum creatinine, chest X-ray, ECG, bleeding time, clotting time. All the patients will be kept nil per oral 8-10 hours for solids and 2 hours for clear fluids. Tablet Alprazolam 0.5 mg and Tablet Pantoprazole 40 mg will be given on the night before surgery. And, at 6 AM on the day of surgery, Injection Pantoprazole 40 mg will be given intravenously. For administration of fluids and drugs, 18G intravenous line will be secured.

The patient will be shifted to pre-operative room and multiparameter monitor will be connected and intravenous fluids will be connected and pre-operative heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, respiratory rate, oxygen saturation, ECG and Diaphragm excursion movement using Ultrasound will be recorded. The superficial cervical plexus block and clavipectoral fascial plane block using 0.375% ropivacaine for Group A patients and superficial cervical plexus block and interscalene brachial plexus block using 0.375% ropivacaine for Group B patients will be given under ultrasound guidance

ULTRASOUND GUIDED SUPERFICIAL CERVICAL PLEXUS BLOCK:

The patient will be placed in a supine position with the head turned to the opposite side of fracture for adequate exposure of the neck and the upper chest. Under strict aseptic precautions, A high-frequency linear ultrasound probe will be placed at the lateral aspect of neck at the level of cricoid cartilage, Once the sternocleidomastoid muscle is identifed, the probe will be moved posteriorly until the posterior tapering end of the muscle is identified. Then, the superficial cervical plexus (SCP) and investing layer of deep cervical fascia will be visualized and 26 Gauge 1.5 inch needle will be introduced by in-plane technique until its tip reaches near the superficial cervical plexus. After careful negative aspiration to exclude intravascular placement, 7 mL of 0.375% ropivacaine will be deposited.

ULTRASOUND GUIDED CLAVIPECTORAL FASCIAL PLANE BLOCK:

The patient will be placed in a supine position with the head turned to the opposite side of the fracture and the shoulder will be padded with a small pillow. Under strict aseptic precautions, A high frequency linear probe will be placed on either side of fractured site on anterior surface of the clavicle and 26 Gauge 1.5 inch needle will be introduced by in-plane technique from caudal to cephalad direction until its tip reaches between periosteum of clavicle and clavipectoral fascia. After careful negative aspiration to exclude intravascular placement, 10 mL of 0.375% ropivacaine will be deposited on either side of fracture site.

ULTRASOUND GUIDED INTERSCALENE BRACHIAL PLEXUS BLOCK:

The patient will be placed in a supine position with the head turned to the opposite side of the fracture and the shoulder will be padded with a small pillow. Under strict aseptic precautions, a high frequency linear probe will be placed at the level of cricoid cartilage to visualize the roots of brachial plexus located between the anterior and middle scalene muscles and 26 Gauge 1.5 inch needle will be introduced by in-plane technique to reach near C5 and C6 nerve roots. After careful negative aspiration to exclude intravascular placement, 20 mL of 0.375% ropivacaine will be deposited to achieve its spread between C5 and C6 nerve roots.

Patient will be placed in a supine position. By using low frequency curvilinear probe of ultrasound the diaphragm will be focussed by keeping it longitudinal at the level of anterior axillary line in subcostal region. Then Motion mode (M-Mode) of the diaphragm is used to detect diaphragmatic excursion along a line selected perpendicular to the diaphragm. Two representative images of diaphragmatic excursion will be saved during tidal volume breath and deep breath respectively. The excursion amplitude will be measured as upright perpendicular distance from minimum to maximum point of diaphragmatic excursion. Diaphragm excursion measurement will be done before giving block as preblock value and after giving block at 30th minute and 4th hour. Hemidiaphragmatic paralysis is defined as more than 50% reduction in diaphragmatic excursion compared with preblock value during deep breaths and/or Paradoxical movements of diaphragm after 30 minutes of giving block